Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21.
暂无分享,去创建一个
[1] W. Telford,et al. Identification of Human Memory‐Like NK Cells , 2017, Current protocols in cytometry.
[2] Dong-Wan Kim,et al. Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors , 2016, Cancer Immunology Research.
[3] J. Houtman,et al. Optimization of Methods for the Genetic Modification of Human T Cells , 2015, Immunology and cell biology.
[4] A. Angulo,et al. Adaptive reconfiguration of the human NK‐cell compartment in response to cytomegalovirus: A different perspective of the host‐pathogen interaction , 2013, European journal of immunology.
[5] L. Zitvogel,et al. Phase I clinical trial combining imatinib mesylate and IL-2 , 2013, Oncoimmunology.
[6] L. Hurton,et al. Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells , 2012, PloS one.
[7] K. Skak,et al. Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression , 2008, Immunology.
[8] C. Le,et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.
[9] A. Schambach,et al. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors , 2015, Journal of Molecular Medicine.
[10] E. Alici,et al. Retroviral gene transfer into primary human natural killer cells. , 2009, Methods in molecular biology.